Role of thymidine phosphorylase on invasiveness and metastasis in lung adenocarcinoma

International Journal of Cancer

Volumn 106, Issue 6, 2003, Pages 863-870

  Sato, Jun ^a   Sata, Makoto ^a   Nakamura, Hidenori ^a   Inoue, Sumito ^a   Wada, Toshihiro ^a   Takabatake, Noriaki ^a   Otake, Kazuhisa ^a   Tomoike, Hitonobu ^a   Kubota, Isao ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Invasion; Lung adenocarcinoma; Metastasis; Thymidine phosphorylase; Tumor differentiation

Indexed keywords

MATRIGEL; PLATELET DERIVED GROWTH FACTOR; THYMIDINE PHOSPHORYLASE;

ARTICLE; BASEMENT MEMBRANE; CANCER INVASION; CHEMOTAXIS; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSFECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; LUNG ADENOCARCINOMA; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; MICROVASCULATURE; PRIORITY JOURNAL; TARGET CELL; TUMOR DIFFERENTIATION;

AGED; ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; CELL DIFFERENTIATION; CELL MOVEMENT; COLLAGEN; DRUG COMBINATIONS; ENZYME INHIBITORS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LAMININ; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; PROTEOGLYCANS; THYMIDINE PHOSPHORYLASE; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 0041837649     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.11315     Document Type: Article

References (39)

1. Furukawa T, Yoshimura A, Sumizawa T, Haraguchi M, Akiyama S. Angiogenic factor. Nature 1992;356:668.
2. Miyazono K, Okabe T, Urabe A, Takaku F, Helden CH. Purification and properties of an endothelial cell growth factor from human platelets. J Biol Chem 1987;262:4098-103.
3. Ishikawa F, Miyazono K, Hellman U. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 1989;338:557-62.
4. Grili R, Oxman AD, Julian JA. Chemotherapy for advanced non-small cell lung cancer: how much benefit is enough? J Clin Oncol 1993;11: 1855-71.
5. Damstrup L, Poulson HS. Review of the curative role of radiotherapy in the treatment of non-small cell lung cancer. Lung Cancer 1994;11: 153-78.
6. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990;82:4-6.
7. Connolly DT. Vascular permeability factor: a unique regulator of blood vessel function. J Cell Biochem 1991;47:219-23.
8. Ohtani H, Nakamura S, Watanabe Y. Immunohistochemical localization of basic fibroblast growth factor in carcinomas and inflammatory lesions of the human digestive tract. Lab Invest 1993;68:520-7.
9. Malden LD, Novak TJ, Burgess AW. Expression of transforming growth factor alpha messenger RNA in the normal and neoplastic gastro-interstinal tract. Int J Cancer 1989;43:380-4.
10. Takebayashi Y, Aiyama S, Akiba S, Yamada K, Miyadera K, Sumizawa T, Yamada Y, Murata F, Aikou T. Clinicopathological and prognostic significance of an angiogenic factor, thymidine phosphorylase in human colorectal carcinoma. J Natl Cancer Inst 1996;88:1110-7.
11. Maeda K, Chung Y, Ogawa Y, Takatsuka S, Kang SM, Ogawa M, Sawada T, Onoda N, Kato Y, Sawa M. Thymidine phosphorylase/platelet-derived endothelial cell growth factor expression associated with hepatic metastasis in gastric carcinoma. Br J Cancer 1996;73:884-8.
12. Toi M, Hoshina S, Taniguchi T, Yamamoto Y, Ishitsuka H, Tominaga T. Expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor in human breast cancer. Int J Cancer 1995;64: 79-82.
13. Reynolds K, Farzaneh F, Collins WP, Campbell S, Bourne TH, Lawton F, Moghaddam A, Harris AL, Bicknell R. Association of ovarian malignancy with expression of PD-ECGF. J Natl Cancer Inst 1994;86:1234-8.
14. Koukourakis MI, Giatromanolaki A, O'Byrne K, Comley M, Whitehouse RM, Talbot DC, Gatter KC, Haris AL. Platelet-derived endothelial cell growth factor expression correlates with tumor angiogenesis and prognosis in non-small cell lung cancer. Br J Cancer 1997; 75:477-81.
15. Koukourakis MI, Giatromanolaki A, Kakolyris S, O'Byrne K, Apostolokas N, Skarlator J, Gatter KC, Harris AL. Differential pattern of stromal and cancer cell thymidine phosphorylase reactivity in nonsmall-cell lung cancer: impact on tumour neoangiogenesis and survival. Br J Cancer 1998;77:1696-703.
16. O'Byrne KJ, Koukourakis MI, Giatromanolaki A, Cox G, Turley H, Steward WP, Gatter KC, Harris AL. Vascular endothelial growth factor, platelet derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer. Br J Cancer 2000;82:1427-32.
17. Imazono Y, Takebayashi Y, Nishiyama K, Akiba S, Miyadera K, Yamada Y, Akiyama S, Ohi Y. Correlation between thymidine phosphorylase expression and prognosis in human renal cell carcinoma. J Clin Oncol 1997;15:2570-8.
18. Takao S, Akiyama SI, Nakajo A, Yoh H, Kitazono M, Natsugoe S, Miyadera K, Fukushima M, Yamada Y, Aikou T. Suppression of metastasis by thymidine phosphorylase inhibitor. Cancer Res 2000: 60:5345-8.
19. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997;111:1710-7.
20. Nishida M, Hino A, Mori K, Matsumoto T, Yoshikubo T, Ishitsuka H. Preparation of anti-human thymidine phosphorylase monoclonal antibodies useful for detecting the enzyme levels in tumor tissues. Biol Pharm Bull 1996;19:1407-11.
21. Giatromanolaki A, Koukourakis MI, Theodossiou D, Barbatis K, O'Byrne K, Harris AL, Gatter KC. Comparative evaluation of angiogenesis assessment with anti-FactorVIII and anti-CD31 immunostaining in non-small cell lung cancer. Clin Cancer Res 1997;3:2493-500.
22. Felgner PL, Gadek TR, Holm M, Roman R, Chan HW, Wenz M, Northrop JP, Ringold GM, Danielsen M. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci USA 1987;84:7413-7.
23. Fukushima M, Suzuki N, Emura T, Yano S, Kazuno H, Tada Y, Yamada Y, Asao T. Structure and activity of specific inhibitors of thymidine phosphorylase to potentiate the function of antitumor 2-deoxyribonucleosides. Biochem Pharmacol 2000;59:1227-36.
24. 3H-thymidine incorporation assay. J Clin Lab Anal 1995;9:89-95.
25. Haraguchi M, Furukawa T, Sumizawa T, Akiyama S. Sensitivity of human KB cells expressing platelet-derived endothelial cell growth factor to pyrimidine antimetabolites. Cancer Res 1993;53:5680-2.
26. Moghaddam A, Zang HT, Fan TPD, Hu DE, Lees VC, Turley H, Fox SB, Gatter KC, Harris AL, Bicknell R. Thymidine phosphorylase is angiogenic and promotes tumor growth. Proc Natl Acad Sci USA 1995;92:998-1002.
27. Yoshimura A, Kuwazuru Y, Akiyama S. Purification and tissue distribution of human thymidine phosphorylase: high expression in lymphocytes, reticulocytes and tumors. Biochim Biophys Acta 1990: 1034:107-13.
28. Pauly JL, Paolin NS, Ebarb RL. Elevated thymidine phosphorylase activity in the plasma and ascitic fluids of tumor-bearing animals. Proc Soc Exp Biol Med 1978;157:262-7.
29. Pauly JL, Schuller MG, Zeler AA. Identification and comparative analysis of thymidine phosphorylase in the plasma of healthy subjects and cancer patients. J Natl Cancer Inst 1997;58:1587-90.
30. Volm M, Koomagi R, Mattern J. PD-ECGF, bFGF, and VEGF expression in non-small cell lung carcinomas and their association with lymph node metastasis. Anticancer Res 1999;19:651-5.
31. Fox SB, Westwood M, Moghaddam A, Comley M, Turkey H, Whitehouse RM, Bicknell R, Gatter KC, Harris AL. The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium. Br J Cancer 1996;73:275-80.
32. Yamashita J, Ogawa M, Abe M, Nishida M. Platelet-derived endothelial cell growth factor/thymidine phosphorylase concentrations differ in small cell and non-small cell lung cancer. Chest 1999;116:206-11.
33. Fox SB, Moghaddam A, Westwood M, Turley H, Bicknell R, Gatter KC, Harris AL. Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: an immunohistochemical study. J Pathol 1995;176:183-90.
34. Haraguchi M, Miyadera K, Uemura K, Sumizawa T, Furukawa T, Yamada K, Akiyama S. Angiogenic activity of enzymes. Nature 1994;368:198.
35. Brown NS, Jones A, Fujiyama C, Harris AL, Bicknell R. Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors. Cancer Res 2000;60:6298-302.
36. Yano T, Takeo S. Thymidine phosphorylase activity in nonsmall cell lung carcinoma tissues. Cancer 2001;92:2658-61.
37. Ueda M, Terai Y, Kumagai K, Ueki K, Kanemura M, Ueki M. Correlation between thymidine phosphorylase expression and invasion phenotype in cervical carcinoma cells. Int J Cancer 2001;91: 778-82.
38. Giatromanolaki A, Koukourakis MI, Comley M, Kaklamanis L, Turkey H, O'Byrne KJ, Harris AL, Gatter KC. Platelet-derived endothelial cell growth factor (thymidine phosphorylase) expression in lung cancer. J Pathol 1997;180:196-9.
39. Helden NH, Usuki K, Bergh J, Westmark B, Helden CH. Differential expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human lung carcinoma cell lines. Br J Cancer 1993;68:708-11.